ABTI — Alterola Biotech Balance Sheet
0.000.00%
- $0.29m
- $0.43m
Annual balance sheet for Alterola Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 September 30th | R2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | — | 0.001 | 0.064 | 0.009 | 0.003 |
| Net Total Receivables | — | — | 0.051 | 0.036 | 0 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.015 | 0.001 | 0.265 | 0.046 | 0.004 |
| Net Intangible Assets | |||||
| Total Assets | 0.015 | 0.001 | 12.3 | 12 | 0.004 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.338 | 0.76 | 1.04 | 2.13 | 1.33 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.338 | 0.76 | 1.2 | 2.29 | 1.33 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.323 | -0.759 | 11.1 | 9.76 | -1.33 |
| Total Liabilities & Shareholders' Equity | 0.015 | 0.001 | 12.3 | 12 | 0.004 |
| Total Common Shares Outstanding |